Standout Papers

Phase III Randomized Trial of FOLFIRI Versus FOLFOX4 in the Treatment of Advanced Colorectal Ca... 2005 2026 2012 2019 570
  1. Phase III Randomized Trial of FOLFIRI Versus FOLFOX4 in the Treatment of Advanced Colorectal Cancer: A Multicenter Study of the Gruppo Oncologico Dell’Italia Meridionale (2005)
    Giuseppe Colucci, Vittorio Gebbia et al. Journal of Clinical Oncology

Immediate Impact

61 standout
Sub-graph 1 of 23

Citing Papers

Augmenting Cancer Therapy with a Supramolecular Immunogenic Cell Death Inducer: A Lysosome-Targeted NIR-Light-Activated Ruthenium(II) Metallacycle
2024 Standout
Ruthenium-Based Photoactivated Chemotherapy
2023 Standout
1 intermediate paper

Works of S. Romito being referenced

Phase III Randomized Trial of FOLFIRI Versus FOLFOX4 in the Treatment of Advanced Colorectal Cancer: A Multicenter Study of the Gruppo Oncologico Dell’Italia Meridionale
2005 Standout

Author Peers

Author Last Decade Papers Cites
S. Romito 632 323 151 219 23 851
You‐Jian He 498 204 196 158 30 790
C. Schlichting 804 396 150 290 16 1.1k
Jian-Ming Xu 569 335 95 171 15 803
Nicola Borsellino 689 322 182 221 19 855
G Paoletti 757 342 149 227 28 944
M. E. Vega-Villegas 931 542 269 224 17 1.2k
Robert S. de Jong 601 231 116 159 21 827
Krzysztof Jeziorski 463 255 172 132 24 791
C.G. Alexopoulos 404 209 120 116 33 761
Eileen Regan 608 233 161 70 34 889

All Works

Loading papers...

Rankless by CCL
2026